- Home
- TIL vs PNI Comparison
TIL vs PNI Comparison
Compare TIL & PNI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TIL
- PNI
- Stock Information
- Founded
- TIL 2018
- PNI 2002
- Country
- TIL United States
- PNI United States
- Employees
- TIL N/A
- PNI N/A
- Industry
- TIL Biotechnology: Pharmaceutical Preparations
- PNI Trusts Except Educational Religious and Charitable
- Sector
- TIL Health Care
- PNI Finance
- Exchange
- TIL Nasdaq
- PNI Nasdaq
- Market Cap
- TIL 230.1M
- PNI 75.2M
- IPO Year
- TIL 2021
- PNI N/A
- Fundamental
- Price
- TIL $24.93
- PNI $6.74
- Analyst Decision
- TIL Buy
- PNI
- Analyst Count
- TIL 5
- PNI 0
- Target Price
- TIL $119.00
- PNI N/A
- AVG Volume (30 Days)
- TIL 354.4K
- PNI 26.4K
- Earning Date
- TIL 08-12-2025
- PNI 01-01-0001
- Dividend Yield
- TIL N/A
- PNI 4.76%
- EPS Growth
- TIL N/A
- PNI N/A
- EPS
- TIL N/A
- PNI N/A
- Revenue
- TIL N/A
- PNI N/A
- Revenue This Year
- TIL N/A
- PNI N/A
- Revenue Next Year
- TIL N/A
- PNI N/A
- P/E Ratio
- TIL N/A
- PNI N/A
- Revenue Growth
- TIL N/A
- PNI N/A
- 52 Week Low
- TIL $9.70
- PNI $6.03
- 52 Week High
- TIL $92.00
- PNI $7.89
- Technical
- Relative Strength Index (RSI)
- TIL 48.54
- PNI 52.83
- Support Level
- TIL $21.80
- PNI $6.64
- Resistance Level
- TIL $30.90
- PNI $6.71
- Average True Range (ATR)
- TIL 3.63
- PNI 0.06
- MACD
- TIL -0.71
- PNI 0.01
- Stochastic Oscillator
- TIL 39.08
- PNI 78.31
About TIL Instil Bio Inc.
Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.
About PNI Pimco New York Municipal Income Fund II of Beneficial Interest
PIMCO New York Municipal Income Fund II is a closed-end management investment company. Its investment objective is to seek to provide current income exempt from federal, New York State and New York City income tax. The fund portfolio of investments consists of investments in different sectors such as education, transportation, healthcare, and others.